«Being able to bridge basic research
with clinical and translational research was important here,» explained Dr. King.
Not exact matches
«The most common time there is conflict of interest is not
with inventorship,» says Harry Greenberg, senior associate dean for
research at the Stanford University School of Medicine in Palo Alto, California, and director of the Stanford Center for Clinical and Translational Education and R
research at the Stanford University School of Medicine in Palo Alto, California,
and director of the Stanford Center for
Clinical and Translational Education
and ResearchResearch.
That priority influences the design of
research questions, Weng notes,
and encourages scientists involved in basic
research, including postdocs, to participate in «very dynamic» collaborations
with translational and clinical groups.
With support from Ohio State's Center for
Clinical and Translational Science (CCTS), Dr. Bonny's
research team was able to comb through past
research to identify the top 30 nutrients that were most likely to influence the growth of fat tissue in a low - estrogen environment.
Regardless of the geographic setting, the goals
and challenges of
translational research are the same, says Liu: Getting funding
and infrastructure support from the government, training young investigators, creating a multidisciplinary community of researchers who can effectively communicate
with each other,
and finding ways to systematically implement
translational research results into
clinical practice.
The world of
clinical and translational research requires the support of individuals
with varying expertise in diverse scientific
and professional languages.
A
clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic
clinical trial conducted by researchers at the Virginia G. Piper Cancer Center
Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic
Clinical Trials, a partnership between Scottsdale Healthcare
and the
Translational Genomics
Research Institute (TGen), showed that a new drug called MM - 398, given in combination
with 5 - flourouracil (5FU)
and leucovorin, produced a significant overall survival rate in patients
with advanced, previously - treated pancreatic cancer.
Together
with the European Renal cDNA Bank
and the Joint Institute for
Translational and Clinical Research (a collaboration between Peking University Health Sciences Center
and U-M), the U-M team found a simple, new test to identify one of the nation's fastest growing chronic illnesses.
For Fuster, «This is a clear example of the type of the collaborative
and translational research favored by the CNIC, in which
research groups
with different interests
and perspectives collaborate on
clinical problems that would not be easily resolved by teams working in isolation.»
«
Clinical and translational medicine represents an important arena of investigation ripe for 21st - century science diplomacy, beginning
with — although by no means limited to — infectious disease
research,» he
and co-author Vaughan Turekian, chief international officer
and director of the AAAS Center for Science Diplomacy, write.
«The exciting
research results being presented today underscore how transplants are becoming an increasingly successful treatment option for more patients
with blood cancer than ever before,» said Jeffrey Miller, MD, moderator of the press conference
and Deputy Director of the Masonic Cancer Center
and the
Clinical and Translational Sciences Institute at the University of Minnesota in Minneapolis.
His primary
clinical and research focus is dementia,
with specific areas of interest including biomarkers to assist in the diagnosis
and understanding of disease mechanisms for Alzheimer's
and Parkinson's disease,
and translational research using novel therapeutic approaches.
William Crowley, director of
clinical research for Massachusetts General Hospital in Boston, observes that, although NIH's many programs to support training in
clinical and translational research have been «spectacular,» the academy is now filled
with well - trained
translational researchers, all trying to land independent
research grants just as the NIH pay line is plummeting.
CTSciNet combines a comprehensive career - development resource
with a soon - to - be-launched online community open to everyone interested in careers in
clinical and translational research.
«Together
with our partners, we are aiming at establishing a
research cluster in the Rhine - Main area that focuses on
translational and clinical research for the treatment of non-alcoholic fatty liver disease,» emphasized Schattenberg
and Schuppan.
«We hope our findings reassure women
with epilepsy
and clinicians who are counseling these women on family planning,» says Jacqueline French, MD, professor of Neurology
and Director of
Translational Research and Clinical Trials at NYU Langone's Comprehensive Epilepsy Center,
and the study's first author
and co-principal investigator.
About EBioMedicine
With the leadership of Cell
and The Lancet, EBioMedicine covers the entire breadth of
translational and clinical research within all disciplines of life
and health sciences, ranging from basic science to
clinical and public / global health science.
The designation recognizes the Center's collaborative environment
and expertise in harnessing
translational research to bridge scientific discovery to
clinical delivery,
with the ultimate goal of successfully introducing novel diagnostic, therapeutic
and preventive approaches to cancer.
On Friday 19 February, CTSciNet, an online community for people pursuing careers in
clinical and translational research who seek to speed the translation of scientific breakthroughs into real - world therapies, will host panel discussion
with top experts in the field.
About the Anna - Maria Kellen
Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
Clinical Accelerator The Anna - Maria Kellen
Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
Clinical Accelerator, the
clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
research program of the Cancer
Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
Research Institute, leverages CRI's partnerships
with nonprofit organizations, pharmaceutical
and biotech companies,
and academic
research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
research and treatment centers worldwide, to provide scientists
and clinicians
with expertise in cancer immunotherapy access to resources they need to advance ambitious
clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede inn
research ideas, while simulataneous solving for competitive
and regulatory hurdles that would otherwise impede innovation.
News
and reports of the latest
clinical trials,
translational medicine, drug development
and research with potential for direct impact on human health.
The Innovative
Translational Research Shared Resource (ITR) partners
with oncologists
and laboratory
and non-laboratory researchers to guide, manage,
and facilitate pre-
clinical and clinical trial laboratory discoveries.
With a team of over 200 researchers, Sanford
Research is comprised of eight groups that bridge bench, translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population
Research is comprised of eight groups that bridge bench,
translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population
research including: Cancer Biology
and Immunotherapies, Pediatrics
and Rare Diseases, Diabetes, Cellular Therapies
and Stem Cell Biology, Enabling Technology, Environmental Influences on Health
and Disease, Genetics
and Genomics,
and Population Health.
The system is available in the multi-mode FLEX configuration, which is designed to meet the needs of high - complexity
clinical laboratories seeking a single platform
with the flexibility to run the Prosigna Breast Cancer Assay
and, when operated in the «Life Sciences» mode, process
translational research experiments
and multiplexed assays developed by the laboratory.
Each of these groups will synergize
with pre-existing excellent
research environments as well as strong
clinical collaborators, promoting ground - breaking
research in molecular
and translational medicine.
Along
with more traditional training experiences, we propose new approaches modeled on interdisciplinary interactions that focus on
translational and clinical research training.
In 1999, Ashworth was appointed the first director of the ICR's Breakthrough Breast Cancer
Research Centre, which is now internationally recognized, with more than 120 scientists and researchers working on aspects of the disease ranging from basic molecular and cellular biology through to translational research and clinical
Research Centre, which is now internationally recognized,
with more than 120 scientists
and researchers working on aspects of the disease ranging from basic molecular
and cellular biology through to
translational research and clinical
research and clinical trials.
«The program will also form an excellent national meeting place for preclinical
and clinical researchers in the WCMM
and SciLifeLab programs
with the ultimate goal of realizing Swedish
translational research from molecule to man.»
Our clinicians work closely
with our scientists on basic,
clinical,
and translational research activities in an effort to advance our understanding of these unique tumors.
Successful candidates will become part of strong
research environments
with excellent infrastructure
and enjoy close collaboration
with AstraZeneca
and clinical /
translational research platforms at one of the largest University hospitals in northern Europe.
Our group is specifically working on improvement of islet isolation
and transplantation protocols in
clinical practice
and the development of novel therapeutic options in the field of beta cell replacement
with a clear
translational «bench to bedside» approach by linking experimental
research with preclinical
and clinical work:
Our collaborative relationships
with pharmaceutical companies, including CSL Ltd, Bristol - Myers Squibb, Sirtex, Roche, Merck
and GlaxoSmithKline, continue to provide basic
and translational clinical research opportunities.
An international peer - reviewed journal, it publishes open access basic
research with a
translational focus, as well as
clinical trials,
research into drug discovery
and development,
and epidemiologic studies.
He is a pediatric oncologist
with an active
clinical and translational research program focused on patients
with advanced neuroblastoma
and Ewing sarcoma.
With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix has the kind of flexibility, security
and data access control today's scientists require for information management of biomarker discovery, next generation biobanking, pre-
clinical and clinical studies
and translational research efforts.
The
clinical biostatistics team has strong connection
with the Biometry department (Head A. Savignoni), the early phase
clinical trial
and precision medicine unit where patients are treated
with drugs in development (Head C. Le Tourneau), the
translational research department in particular the Circulating Tumor Biomarkers laboratory (Charlotte Proudhon),
and of course the other teams of the U900.
The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia
and workshops in the field of pharmacogenetics
and genomics, to evaluate the
clinical impact of pharmacogenetics, to assist
with the development
and maintenance of drug - related pharmacogenetic databases
and to create a population based biobank to conduct
translational research in
clinical pharmacogenomics.
Institut Curie's SIRIC (Integrated Cancer
Research Site) status further improves the structure of its translational and clinical research, enables it to develop interdisciplinary programmes with basic research units, and helps it share the resultant kn
Research Site) status further improves the structure of its
translational and clinical research, enables it to develop interdisciplinary programmes with basic research units, and helps it share the resultant kn
research, enables it to develop interdisciplinary programmes
with basic
research units, and helps it share the resultant kn
research units,
and helps it share the resultant knowledge.
The expertise displayed by the teams
and the platforms of the Department of
Translational Research allows the support for maturation of translational research projects (proof of concept in vivo, target / biomarker identification and validation, ancillary biological studies coupled to clinical trials,...) of the Institut Curie alone or in collaboration with other academic teams or industr
Translational Research allows the support for maturation of translational research projects (proof of concept in vivo, target / biomarker identification and validation, ancillary biological studies coupled to clinical trials,...) of the Institut Curie alone or in collaboration with other academic teams or industrial p
Research allows the support for maturation of
translational research projects (proof of concept in vivo, target / biomarker identification and validation, ancillary biological studies coupled to clinical trials,...) of the Institut Curie alone or in collaboration with other academic teams or industr
translational research projects (proof of concept in vivo, target / biomarker identification and validation, ancillary biological studies coupled to clinical trials,...) of the Institut Curie alone or in collaboration with other academic teams or industrial p
research projects (proof of concept in vivo, target / biomarker identification
and validation, ancillary biological studies coupled to
clinical trials,...) of the Institut Curie alone or in collaboration
with other academic teams or industrial partners.
We identify
and advance therapeutics into
clinical trials for children
with brain cancer,
with increasing focus on types of brain tumors that are uncommon
and have the greatest need for
translational research.
With ongoing studies in cancer care quality, outcomes prediction,
clinical epidemiology,
and medical decision making, we have a comprehensive portfolio of practice -
and policy - relevant
translational population sciences
research in urologic cancers, building on the exceptional strengths of UNC Lineberger.
In this review, we argue that
translational research should be seen as enabled by ongoing efforts in basic
and clinical research and not competing
with them.
In addition, I work closely
with colleagues in Lineberger on innovative
clinical trials
and translational research projects directed at developing novel strategies for the treatment of advanced disease.
Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly innovative pilot projects focusing on proof - of - concept or
translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant awards or
clinical trial; (3) projects that closely align
with the Cancer Center's strategic plan
and enhance key initiatives;
and (4) pilot funding for junior investigators to jump - start independent projects or for more senior investigators looking to study a novel idea derived from discovery.
The RegMed Track links basic molecular
and cellular
research with translational and clinical studies,
and includes stem cell biology, molecular medicine, regenerative biology
and translational research.
With a mission to share the newest scientific concepts
and research findings shaping
clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States
and the world who represent dozens of scientific areas, from laboratory to
translational to
clinical research.
When UC San Diego Jacobs Medical Center opens in 2016, blood
and marrow transplant patients will have rooms
with panoramic views
and leading - edge treatments such as stem cell - directed
clinical translational research.
Dr. Mohan specializes in the treatment of myelodysplastic syndromes
and acute myeloid leukemia,
with a focus on
clinical trials
and on
translational research into secondary leukemias.
Clinical Research Advocacy — Collaborating with other professional organizations to promote the advancement and support of clinical and translational research to Congress and federal
Clinical Research Advocacy — Collaborating with other professional organizations to promote the advancement and support of clinical and translational research to Congress and federal
Research Advocacy — Collaborating
with other professional organizations to promote the advancement
and support of
clinical and translational research to Congress and federal
clinical and translational research to Congress and federal
research to Congress
and federal agencies
The
Clinical Research Forum believes that continued success for our nation's translational research enterprise will require the development of an integrated system with the capacity to efficiently translate a burgeoning pipeline of basic research into high quality clinical care and improved health o
Clinical Research Forum believes that continued success for our nation's translational research enterprise will require the development of an integrated system with the capacity to efficiently translate a burgeoning pipeline of basic research into high quality clinical care and improved health o
Research Forum believes that continued success for our nation's
translational research enterprise will require the development of an integrated system with the capacity to efficiently translate a burgeoning pipeline of basic research into high quality clinical care and improved health o
research enterprise will require the development of an integrated system
with the capacity to efficiently translate a burgeoning pipeline of basic
research into high quality clinical care and improved health o
research into high quality
clinical care and improved health o
clinical care
and improved health outcomes.